SCHEMBL23626880

SCHEMBL23626880

c1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccc5c(c4)oc4cc(-n6c7ccccc7c7cccnc76)ccc45)n3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ PIK3CA P42336 1/20 0.31
▸ ABCG2 Q9UNQ0 4/20 0.31
▸ PTGER4 P35408 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ PTK2B Q14289 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ FEN1 P39748 1/20 0.30
▸ MMP12 P39900 1/20 0.30
▸ MMP13 P45452 1/20 0.30
▸ PDE4A P27815 1/20 0.30
▸ KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26082200 1.00 ALDH1A1 (0.36) ALDH1A1TSHRCYP2C19PIK3CAABCG2
SCHEMBL26082170 0.97 ALDH1A1 (0.38) ALDH1A1TSHRCYP2C19PIK3CAABCG2
SCHEMBL26082176 0.97 ALDH1A1 (0.38) ALDH1A1TSHRCYP2C19PIK3CAABCG2
SCHEMBL26082258 0.95 ALDH1A1 (0.34) ALDH1A1TSHRCYP2C19PTGER4MAPT
SCHEMBL26082178 0.94 ALDH1A1 (0.37) ALDH1A1TSHRCYP2C19PIK3CAABCG2
SCHEMBL23626811 0.92 ALDH1A1 (0.36) ALDH1A1TSHRCYP2C19PIK3CAABCG2
SCHEMBL23626836 0.91 ALDH1A1 (0.33) ALDH1A1TSHRCYP2C19PIK3CAPTGER4
SCHEMBL26082202 0.91 ALDH1A1 (0.34) ALDH1A1TSHRCYP2C19PTGER4
SCHEMBL23626876 0.91 ALDH1A1 (0.35) ALDH1A1TSHRCYP2C19PIK3CAABCG2
SCHEMBL26082171 0.91 ALDH1A1 (0.35) ALDH1A1TSHRCYP2C19PIK3CAPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-16 — — US disclosed
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-01-16 — — US disclosed
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 — — US disclosed
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 — — US disclosed
WO-2021136277-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2021-07-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312604-A1 HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE ODC1, LEF1, PIEZO1 ALDH1A1 137/4885TSHR 3792/4885CYP2C19 29/4885
US-11873311-B2 Heterocyclic compound, organic electroluminescent device, and electronic device ODC1, LEF1, PIEZO1 ALDH1A1 137/4885TSHR 3792/4885CYP2C19 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback